Infectious and Inflammatory Diseases

Prof. Dor Salomon

Antibacterial treatment

The World Health Organization predicts that by 2050, multidrugresistant pathogens will become the leading cause of death worldwide To prevent this catastrophe, the development of novel antibacterial treatments is necessary Prof Salomon is employing multidisciplinary approaches to study mechanisms and toxins that are used by https://www.dorsalomonlab.sites.tau.ac.il/ bacteria to neutralize their bacterial competitors. By adapting and customengineering these natural antibacterial mechanisms, Prof. Salomon is developing nextgeneration antibacterial treatments and prophylactics.

Prof. Salomon, PhD, is at the Department of Clinical Microbiology and Immunology. He completed his PhD (Dean’s direct track) at Tel Aviv University, followed by a Postdoctoral fellowship at the University of Texas Southwestern Medical Center. Prof. Salomon was awarded the NIH Pathway to Independence Award (K99/R00) and was also awarded the Alon Fellowship for young investigators and the prestigious European Research Council (ERC) starting grant. During the period of COVID-19 quarantine, he organized a virtual international conference with over 400 participants, named T6SympoZOOM.